Multiple System Atrophy - Cerebellar Type: Clinical Picture and Treatment of an Often-Overlooked Disorder
- PMID: 33173654
- PMCID: PMC7645310
- DOI: 10.7759/cureus.10741
Multiple System Atrophy - Cerebellar Type: Clinical Picture and Treatment of an Often-Overlooked Disorder
Abstract
Multiple system atrophy (MSA) is a rare, progressive, fatal, neurodegenerative disorder. There are two main types: the parkinsonian type (MSA-P) and cerebellar type (MSA-C). The disease usually presents with genitourinary dysfunction, orthostatic hypotension, and rapid eye movement (REM) sleep behavior disorder. Patients rapidly develop balance, speech, and coordination abnormalities. We present a review of the clinical picture and the actualized treatment modalities of the MSA cerebellar type. For the study methods, a PubMed search was done using the following medical subject headings (MeSH) terms: "multiple system atrophy/therapy". Inclusion criteria included studies in English, full papers, human studies, and publications in the last 30 years. Case reports and series were excluded. A total of 157 papers were extracted after applying the inclusion and exclusion criteria, and 41 papers were included for the discussion of this review. This review underlines the therapeutic strategies as well as the clinical picture of multiple system atrophy, and how MSA-C and MSA-P differ from each other. We discussed this review in four topics: ataxia, autonomic dysfunction (neurogenic orthostatic hypotension and urinary disorders), parkinsonism, and REM sleep disorder. In conclusion, the treatment of MSA-C is mainly symptomatic; there are not many studies on MSA-C. The ataxic component and fewer parkinsonian symptoms are the main difference of MSA-C as opposed to MSA-P.
Keywords: ataxia; autonomic dysfunction; multiple system atrophy; parkinsonism; sleep-wake disorder.
Copyright © 2020, Ortiz et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.Cerebellum. 2016 Dec;15(6):663-679. doi: 10.1007/s12311-015-0728-y. Cerebellum. 2016. PMID: 26467153 Free PMC article.
-
Does the Type of Multisystem Atrophy, Parkinsonism, or Cerebellar Ataxia Impact on the Nature of Sleep Disorders?Curr Neurol Neurosci Rep. 2016 Dec;16(12):105. doi: 10.1007/s11910-016-0704-z. Curr Neurol Neurosci Rep. 2016. PMID: 27844341 Review.
-
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.Mov Disord. 2010 Nov 15;25(15):2604-12. doi: 10.1002/mds.23192. Mov Disord. 2010. PMID: 20922810
-
Natural history of multiple system atrophy in the USA: a prospective cohort study.Lancet Neurol. 2015 Jul;14(7):710-9. doi: 10.1016/S1474-4422(15)00058-7. Epub 2015 May 27. Lancet Neurol. 2015. PMID: 26025783 Free PMC article.
-
A Review on the Clinical Diagnosis of Multiple System Atrophy.Cerebellum. 2023 Oct;22(5):825-839. doi: 10.1007/s12311-022-01453-w. Epub 2022 Aug 19. Cerebellum. 2023. PMID: 35986227 Free PMC article. Review.
Cited by
-
A challenging case presentation of multiple system atrophy cerebellar type: A rare case report from Somalia.Radiol Case Rep. 2024 Sep 23;19(12):6183-6186. doi: 10.1016/j.radcr.2024.08.145. eCollection 2024 Dec. Radiol Case Rep. 2024. PMID: 39376957 Free PMC article.
-
Nature of Parkinsonian features in multiple system atrophy.J Neurosci Rural Pract. 2024 Apr-Jun;15(2):211-216. doi: 10.25259/JNRP_445_2023. Epub 2023 Dec 16. J Neurosci Rural Pract. 2024. PMID: 38746510 Free PMC article.
-
Long-Term Clinical Efficacy of Human Umbilical Cord Blood Mononuclear Cell Transplantation by Lateral Atlanto-Occipital Space Puncture (Gong's Puncture) for the Treatment of Multiple System Atrophy.Cell Transplant. 2022 Jan-Dec;31:9636897221136553. doi: 10.1177/09636897221136553. Cell Transplant. 2022. PMID: 36354017 Free PMC article.
-
Use of Riluzole for the Treatment of Hereditary Ataxias: A Systematic Review.Brain Sci. 2022 Aug 5;12(8):1040. doi: 10.3390/brainsci12081040. Brain Sci. 2022. PMID: 36009103 Free PMC article. Review.
-
Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model.Acta Pharmacol Sin. 2024 Jan;45(1):66-75. doi: 10.1038/s41401-023-01138-y. Epub 2023 Aug 21. Acta Pharmacol Sin. 2024. PMID: 37605049 Free PMC article.
References
-
- Multiple system atrophy of the cerebellar type: clinical state of the art. Lin DJ, Hermann KL, Schmahmann JD. Mov Disord. 2014;29:294–304. - PubMed
-
- Multiple-system atrophy. Fanciulli A, Wenning GK. N Engl J Med. 2015;3:249–263. - PubMed
-
- A cross-sectional study on drug use in multiple system atrophy. Rey MV, Perez-Lloret S, Pavy-Le Traon A, Meissner WG, Tison F, & Rascol O. CNS Drugs. 2014;28:483–490. - PubMed
Publication types
LinkOut - more resources
Full Text Sources